Effect of endoscopic ultrasound guided celiac plexus block on the palliation of pain in chronic pancreatitis (EPOCH Trial): study protocol for a randomized multicenter sham-controlled trial {1}.
Humans
Celiac Plexus
Pancreatitis, Chronic
/ complications
Abdominal Pain
/ etiology
Endosonography
Autonomic Nerve Block
/ methods
Randomized Controlled Trials as Topic
Multicenter Studies as Topic
Pain Measurement
Ultrasonography, Interventional
Treatment Outcome
Palliative Care
/ methods
Nerve Block
/ methods
Prospective Studies
United States
Time Factors
Abdominal pain
Celiac plexus block
Chronic pancreatitis
Endoscopic ultrasonography
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
14 Oct 2024
14 Oct 2024
Historique:
received:
26
04
2024
accepted:
17
09
2024
medline:
14
10
2024
pubmed:
14
10
2024
entrez:
13
10
2024
Statut:
epublish
Résumé
Celiac plexus block has been commonly utilized for the treatment of chronic pancreatitis-associated abdominal pain. Prospective studies suggest efficacy in 30 to 50% of patients, although no randomized sham-controlled trials have been performed. The objective of this study is to assess the effect of endoscopic ultrasound (EUS)-guided celiac plexus block on abdominal pain in patients with documented chronic pancreatitis. This is a two-arm randomized sham-controlled trial with blinded evaluators. The study will be conducted at multiple academic sites in the United States who are members of the United States Pancreatic Disease Study Group (USPG). Patients referred for EUS to exclude chronic pancreatitis as a cause of abdominal pain as well as those with established painful chronic pancreatitis undergoing EUS for another indication will be eligible. At the time of EUS with confirmation of chronic pancreatitis by standard EUS diagnostic criteria, patients will be randomized to either celiac plexus block or sham whereby an anesthetic and steroid combination will be injected into the celiac plexus or saline will be injected into the gastric lumen with the same type of needle as used for celiac plexus block, respectively. The main outcome measure will be a 50% reduction in abdominal pain using the Brief Pain Inventory Short Form (BPI-SF) at 1 month post-intervention. A number of secondary outcomes will be measured including visual analog scale (VAS), Comprehensive Pain Assessment Tool Short Form (COMPAT-SF) pain scores, and quality of life using a pancreas-specific validated measure (PANQOLI). In this study, the effect of celiac plexus block on abdominal pain in patients with chronic pancreatitis will be compared to a sham intervention. This randomized trial will offer a definitive assessment of the role of celiac plexus block for the treatment of abdominal pain in this setting. TRIAL REGISTRATION {2}: ClinicalTrials.gov NCT06178315. Registered on December 21, 2023.
Sections du résumé
BACKGROUND
BACKGROUND
Celiac plexus block has been commonly utilized for the treatment of chronic pancreatitis-associated abdominal pain. Prospective studies suggest efficacy in 30 to 50% of patients, although no randomized sham-controlled trials have been performed. The objective of this study is to assess the effect of endoscopic ultrasound (EUS)-guided celiac plexus block on abdominal pain in patients with documented chronic pancreatitis.
METHODS
METHODS
This is a two-arm randomized sham-controlled trial with blinded evaluators. The study will be conducted at multiple academic sites in the United States who are members of the United States Pancreatic Disease Study Group (USPG). Patients referred for EUS to exclude chronic pancreatitis as a cause of abdominal pain as well as those with established painful chronic pancreatitis undergoing EUS for another indication will be eligible. At the time of EUS with confirmation of chronic pancreatitis by standard EUS diagnostic criteria, patients will be randomized to either celiac plexus block or sham whereby an anesthetic and steroid combination will be injected into the celiac plexus or saline will be injected into the gastric lumen with the same type of needle as used for celiac plexus block, respectively. The main outcome measure will be a 50% reduction in abdominal pain using the Brief Pain Inventory Short Form (BPI-SF) at 1 month post-intervention. A number of secondary outcomes will be measured including visual analog scale (VAS), Comprehensive Pain Assessment Tool Short Form (COMPAT-SF) pain scores, and quality of life using a pancreas-specific validated measure (PANQOLI).
DISCUSSION
CONCLUSIONS
In this study, the effect of celiac plexus block on abdominal pain in patients with chronic pancreatitis will be compared to a sham intervention. This randomized trial will offer a definitive assessment of the role of celiac plexus block for the treatment of abdominal pain in this setting. TRIAL REGISTRATION {2}: ClinicalTrials.gov NCT06178315. Registered on December 21, 2023.
Identifiants
pubmed: 39396987
doi: 10.1186/s13063-024-08478-y
pii: 10.1186/s13063-024-08478-y
doi:
Banques de données
ClinicalTrials.gov
['NCT06178315']
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
676Investigateurs
Akwi Asombang
(A)
Chloe Bennett
(C)
Yan Bi
(Y)
Wojciech Blogowski
(W)
Wei-Shen Chin
(WS)
Darwin Conwell
(D)
Gregory A Coté
(GA)
Pramod Garg
(P)
Nalini Guda
(N)
Yasmin G Hernandez-Barco
(YG)
Emily Jonica
(E)
Thomas Kowalski
(T)
Vivek Kumbhari
(V)
Linda Lee
(L)
Jorge Machicado
(J)
Desiree Morgan
(D)
Veeral Oza
(V)
Swati Pawa
(S)
Rajesh Puri
(R)
Amit Rastogi
(A)
D Nageshwar Reddy
(DN)
Monica Saumoy
(M)
Mandeep Sawhney
(M)
Santhi Swaroop Vege
(SS)
Rupjyoti Talukdar
(R)
Felix Tellez-Avila
(F)
Nikhil Thiruvengadam
(N)
Elaina Vivian
(E)
Field F Willingham
(FF)
Informations de copyright
© 2024. The Author(s).
Références
Whitcomb DC, Frulloni L, Garg P, et al. Chronic pancreatitis: an international draft consensus proposal for a new mechanistic definition. Pancreatology. 2016;16:218–24.
doi: 10.1016/j.pan.2016.02.001
pubmed: 26924663
Drews AM, Bouwense SA, Campbell CM, et al. Guidelines for the understanding and management of pain in chronic pancreatitis. Pancreatology. 2017;17:720–31.
doi: 10.1016/j.pan.2017.07.006
de Rijk F, van Veldhuisen C, Kempeneers M, et al. Quality of life in patients with definite chronic pancreatitis: a nationwide longitudinal cohort study. Am J Gastroenterol. 2023;118:1428–38.
doi: 10.14309/ajg.0000000000002266
pubmed: 36996496
Machicado JD, Amann ST, Anderson MA, et al. Quality of life in chronic pancreatitis is determined by constant pain, disability/unemployment, current smoking, and associated co-morbidities. Am J Gastroenterol. 2017;112:633–42.
doi: 10.1038/ajg.2017.42
pubmed: 28244497
pmcid: 5828017
Blachnio K, Szymocha A, Kovalsky M, et al. Quality of life and pain in patients with chronic pancreatitis. Pancreas. 2023;52:321–7.
doi: 10.1097/MPA.0000000000002262
Abu-El-Haija M, Anazawa T, Beilman GJ, et al. The role of total pancreatectomy with islet autotransplantation in the treatment of chronic pancreatitis: a report from the international consensus guidelines in chronic pancreatitis. Pancreatology. 2020;20:762–71.
doi: 10.1016/j.pan.2020.04.005
pubmed: 32327370
Bell S, Cole R, Roberts-Thomson I. Coeliac plexus block for control of pain in chronic pancreatitis. Br Med J. 1980;281:1604.
doi: 10.1136/bmj.281.6255.1604
pubmed: 7448534
pmcid: 1715073
Gress F, Schmitt C, Sherman S, Ciaccia D, Ikenberry S, Lehman G. A prospective randomized comparison of endoscopic ultrasound and computed tomography-guided celiac plexus block for managing chronic pancreatitis pain. Am J Gastroenterol. 1999;94:900–5.
doi: 10.1111/j.1572-0241.1999.01042.x
pubmed: 10201454
Stevens T, Costanzo A, Lopez R, Kapural L, Parsi MA, Vargo JJ. Adding triamcinolone to endoscopic ultrasound-guided celiac plexus blockade does not reduce pain in patients with chronic pancreatitis. Clin Gastroenterol Hepatol. 2012;10:186–91.
doi: 10.1016/j.cgh.2011.09.006
pubmed: 21946121
ASGE Standards of Practice Committee, Sheth SG, Machicado, et al. American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the management of chronic pancreatitis: summary and recommendations. Gastrointest Endosc. 2024:S0016–5107. In press.
Kaufman M, Singh G, Das S, et al. Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol. 2010;44:127–34.
doi: 10.1097/MCG.0b013e3181bb854d
pubmed: 19826273
Puli SR, Reddy JBK, Bechtold ML, Antillon MR, Brugge WR. EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pan: a meta-analysis and systemic review. Dig Dis Sci. 2009;54:2330–7.
doi: 10.1007/s10620-008-0651-x
pubmed: 19137428
Wilcox CM. Tinkering with a tarnished technique: isn’t it time to abandon celiac plexus blockade for the treatment of abdominal pain in chronic pancreatitis? Clin Gastroenterol Hepatol. 2012;10:106–8.
doi: 10.1016/j.cgh.2011.10.039
pubmed: 22079511
Hohenschurz-Schmidt D, Cherkin D, Rice ASC, et al. Methods for pragmatic randomized clinical trials of pain therapies: IMMPACT statement. Pain. 2024;00:1–19.
Kuhlmann L, Teo K, Olesen SS, et al. Development of the comprehensive pain assessment tool short form for chronic pancreatitis: validity and reliability testing. Clin Gastroenterol Hepatol. 2022;20:e770–83.
doi: 10.1016/j.cgh.2021.05.055
pubmed: 34089847
Wassef W, DeWitt J, McGreevy K, et al. Pancreatitis quality of life instruments: a psychometric evaluation. Am J Gastroenterol. 2016;111:1177–86.
doi: 10.1038/ajg.2016.225
pubmed: 27296943
Hart P, Anderson D, Lyons E, et al. Clinical trials in pancreatitis: opportunities and challenges in the design and conduct of patient-focused clinical trials in recurrent acute and chronic pancreatitis: summary of a national institute of diabetes and digestive and kidney diseases workshop. Pancreas. 2022;51:715–22.
doi: 10.1097/MPA.0000000000002105
pubmed: 36395394
pmcid: 9697224
Del Pozo D, Loves E, Tabernero S, et al. Conventional versus Rosemont endoscopic ultrasound criteria for chronic pancreatitis: interobserver agreement in same day back-to-back procedures. Pancreatology. 2012;12:284–7.
doi: 10.1016/j.pan.2012.03.054
pubmed: 22687386
Mullady DK, Yadav D, Amann ST, et al. Type of pain, pain-associated complications, quality of life, disability and resource utilisation in chronic pancreatitis: a prospective cohort study. Gut. 2011;60:77–84.
doi: 10.1136/gut.2010.213835
pubmed: 21148579
Cartelle AL, Shah I, Bocchino R, et al. Long-term follow-up of disabled patients with chronic pancreatitis: evaluation of clinical characteristics, outcomes, and predictors. J Clin Gastroenterol. 2024;58:98–102.
doi: 10.1097/MCG.0000000000001804
Bouwense SA, Olesen SS, Drewes AM, et al. Effects of pregabalin on central sensitization in patients with chronic pancreatitis in a randomized controlled trial. PLoS One. 2012;7:e42096.
doi: 10.1371/journal.pone.0042096
pubmed: 22879908
pmcid: 3412837
Bouwense SA, de Vries M, Schreuder LT, et al. Systematic mechanism-oriented approach to chronic pancreatitis pain. World J Gastroenterol. 2015;21:47–59.
doi: 10.3748/wjg.v21.i1.47
pubmed: 25574079
pmcid: 4284360
Parhiala M, Nojgaard C, Bartholdy A, et al. Quality of life after endoscopic procedures for chronic pancreatitis: a multicentre study. United European Gastroenterol J. 2023;11:884–93.
doi: 10.1002/ueg2.12466
pubmed: 37812591
pmcid: 10637126
Cassar N, Cromwell P, Duggan S, et al. Surgery versus endoscopy for the management of painful chronic pancreatitis: a systematic review and meta-analysis of randomized trials. Dig Surg. 2024;41:1–11 (in press).
doi: 10.1159/000535588
pubmed: 38190810
Issa Y, Kempeneers MA, Bruno MJ, et al. Effect of early surgery vs endoscopy-first approach on pain in patients with chronic pancreatitis. The ESCAPE randomized clinical trial. JAMA. 2020;323:237–47.
doi: 10.1001/jama.2019.20967
pubmed: 31961419
pmcid: 6990680
Talukdar R, Olesen SS, Unnisa M, et al. Extracorporeal shock-wave lithotripsy and endoscopy for the treatment of pain in chronic pancreatitis: a sham-controlled, randomized trial. Ann Intern Med. 2024;177:749–58.
doi: 10.7326/M24-0210
pubmed: 38801774
Wilcox CM. Exploring the use of the sham design for interventional trials: implications for endoscopic research. Gastrointest Endosc. 2008;67:123–7.
doi: 10.1016/j.gie.2007.09.003
pubmed: 18155434
Cotton PB, Durkalski V, Romagnuolo J, et al. Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial. JAMA. 2014;311:2101–9.
doi: 10.1001/jama.2014.5220
pubmed: 24867013
pmcid: 4428324
Palma C, David C, Fernandes RM, et al. The sham effect of invasive interventions in chronic coronary syndromes: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2022;22:223.
doi: 10.1186/s12872-022-02658-x
pubmed: 35568808
pmcid: 9107755